|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||81.18 - 82.72|
|52 Week Range||74.45 - 91.79|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.14%|
The US Bureau of Labor Statistics releases a monthly report that tracks price trends in wholesale markets. Industries from the manufacturing sector (XLI) are surveyed for changes in input prices, and this survey data is used to construct the PPI (Producer Price Index). The survey comprises questions on raw material prices, production levels, and finished goods.
The “Job Openings and Labor Turnover Survey” (or JOLTS) data for February was reported on April 13, and it contains information about job openings and total separations. The total number of separations includes layoffs, retirements, and voluntary quitting. As per the latest JOLTS report, the total separations for February was 5.2 million at a rate of 3.5% of the total workforce and a decrease from the January reading of 5.9 million and 4.1%, respectively.
Investors solely focusing on large-cap health care stocks and exchange-traded funds this year are likely disappointed. Entering Tuesday, the Health Care Select Sector SPDR (NYSE: XLV), the largest ETF by assets tracking the sector, was up just 0.2 percent year-to-date. For investors willing to take on a little more risk with their health care investments, noteworthy is the fact that the size effect is working with health care stocks this year.
As we approach another earnings season, medical-device companies look poised to report quarters in line with expectations. At least that's the warning from Morgan Stanley's David Lewis. He writes that first-quarter fundamentals look encouraging for the group, given a favorable utilization environment at the start of the year—and a more severe flu season than usual that could serve as another tailwind. Among large-caps in the space, Lewis says Intuitive Surgical (ISRG), Becton Dickinson (BDX), and Zimmer Biomet (ZBH) have a good chance of beating expectations.
Pharmaceutical ETFs are securities that are publicly traded on stock markets and designed for investors who don’t have the capacity to hold many stocks but are willing to diversify their investments within the pharmaceutical sector.
While it’s been easy to lose sight of individual sectors amid the market’s recent volatility, there’s been no shortage of health-care news lately, including Incyte’s (INCY) 20% plunge on Friday, after its cancer treatment epacadostat failed in a late-stage trial. Merck (MRK), whose blockbuster drug Keytruda was being tested with epacadostat, bounced back quickly: The shares are higher on Monday, thanks to upbeat data from a lung cancer trial. Meanwhile AbbVie (ABBV) is climbing on news that its rheumatoid arthritis drug showed positive results in a late-stage trial.
The ADP March jobs report was published on April 4, 2018. It offered a deeper insight into employment trends across different sectors in the US employment market. ADP and Moody’s analytics prepare this monthly report.
The health care sector has performed only slightly better than the broader market this year. For example, the Health Care Select Sector SPDR (NYSE: XLV ) is off 0.6 percent, while the S&P 500 is lower ...
The healthcare sector, as measured by the Health Care Select Sector SPDR ETF (NYSEARCA:XLV), is down 1.5% so far in 2018, but even as the group as a whole struggles one of my favorite NexGen healthcare names is up more than 20%: Teladoc Inc (NYSE:TDOC). Teladoc is the leader in the emerging telehealth industry. In the future, the days of spending hours in a doctor’s office only for them to tell you that you have a sinus infection and need some antibiotics will be non-existent.
On March 20, 2018, Teva Pharmaceutical (TEVA) ended the trading day at a closing price of $17.68. Recently, on February 15, 2018, TEVA stock registered a rise of ~10.5% triggered by the news of an investment of $358 million in the company by Berkshire Hathaway. This news led to the market’s gaining some confidence in the troubled stock, as Berkshire Hathaway investments have been synonymous with value investments.
January’s JOLTS (Job Openings and Labor Turnover Survey) data, which contains information about job openings and total separations, was reported on March 16. The separation total includes layoffs, retirements, and voluntary quits. Total separations in January stood at 5.9 million, representing 4.1% of the total workforce and a minor increase from the December reading of 5.1 million.